\nConform CNN, compania a realizat un studiu pe 170 de cazuri de vountari infecta\u0163i cu SARS-Cov-2. Dintre aceste cazuri, 162 de infec\u0163ii au fost la persoanele c\u0103rora li s-a administrat placebo sau vaccinuri cu solu\u0163ie salin\u0103 simpl\u0103, \u00een timp ce opt cazuri au fost la participan\u0163ii care au primit vaccinul propriu-zis. Acest lucru rezult\u0103 o eficacitate de 95%, a spus Pfizer.<\/p>\n
Datele ini\u0163iale ar\u0103tau o eficien\u0163\u0103 de peste 90%, potrivit Pfizer.<\/p>\n
\u201eEficacitatea a fost constant\u0103 \u00een func\u0163ie de v\u00e2rst\u0103, ras\u0103 \u015fi etnie. Eficacitatea observat\u0103 la adul\u0163ii cu v\u00e2rsta peste 65 de ani a fost de peste 94%,” au declarat Pfizer \u015fi partenerul s\u0103u german BioNTech \u00eentr-o declara\u0163ie comun\u0103.<\/p>\n
\u201eAu fost 10 cazuri severe de Covid-19 observate \u00een proces, cu nou\u0103 dintre cazuri care au ap\u0103rut \u00een grupul placebo \u015fi unul \u00een grupul vaccinat,\u201d au ad\u0103ugat cele dou\u0103 companii.<\/p>\n
Un grup independent a urm\u0103rit rezultatele \u015fi efectele secundare. \u201eP\u00e2n\u0103 \u00een prezent, Comitetul de monitorizare a datelor pentru studiu nu a raportat nicio problem\u0103 serioas\u0103 de siguran\u0163\u0103 legat\u0103 de vaccin\u201d, au anun\u0163at companiile.<\/p>\n
\u201eSingurul efect advers a fost oboseala, la 3,7% dintre pacien\u0163i\u201d, potrivit celor dou\u0103 companii.<\/p>\n
Pfizer a declarat c\u0103 va solicita FDA autoriza\u0163ia de utilizare de urgen\u0163\u0103 a vaccinului \u201e\u00een c\u00e2teva zile\u201d.<\/p>\n
\u201eAceste date vor fi, de asemenea, transmise altor agen\u0163ii de reglementare din \u00eentreaga lume”, a spus Pfizer. Compania inten\u0163ioneaz\u0103 s\u0103 publice datele \u015fi \u00eentr-o revist\u0103 \u015ftiin\u0163ific\u0103.<\/p>\n
\u201eProtec\u0163ia rapid\u0103 pe care o ofer\u0103 acest vaccin – combinat\u0103 cu profilul s\u0103u de tolerabilitate la toate grupele de v\u00e2rst\u0103 studiate p\u00e2n\u0103 acum – ar trebui s\u0103 contribuie la transformarea acestui vaccin \u00eentr-un instrument important pentru abordarea pandemiei actuale,\u201d a declarat dr. Ugur Sahin, CEO \u015fi cofondator al BioNTech.<\/p>\n
Pfizer a declarat pe 9 noiembrie c\u0103 datele intermediare au furnizat dovezi ini\u0163iale c\u0103 vaccinul avea o eficacitate de peste 90%. Aceste date s-au bazat pe primele 94 de cazuri de infec\u0163ie cu coronavirus \u00een r\u00e2ndul voluntarilor. Compania a spus la momentul respectiv c\u0103 va trebui s\u0103 numere mai multe cazuri de infec\u0163ie \u00een cadrul procesului \u00eenainte de a putea lua \u00een considerare partea de faz\u0103 3 a procesului \u015fi a solicita autoriza\u0163ia FDA.<\/p>\n","protected":false},"excerpt":{"rendered":"
O analiz\u0103 final\u0103 a studiului de faz\u0103 3 a vaccinului coronavirus Pfizer arat\u0103 c\u0103 are o eficien\u0163\u0103 de 95% \u00een prevenirea infec\u0163iilor, chiar \u015fi la adul\u0163ii \u00een v\u00e2rst\u0103, \u015fi nu a cauzat probleme serioase de siguran\u0163\u0103, a declarat compania miercuri.<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[510],"tags":[47243,7853],"class_list":["post-188200","post","type-post","status-publish","format-standard","hentry","category-actualitate","tag-pzifer","tag-studiu"],"_links":{"self":[{"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/posts\/188200","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=188200"}],"version-history":[{"count":0,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/posts\/188200\/revisions"}],"wp:attachment":[{"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=188200"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=188200"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=188200"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}